Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
Since 2017, targeted therapies combined with conventional intensive chemotherapy have started to improve outcome of patients with acute myeloid leukemia (AML). However, even before these innovations outcomes with intensive chemotherapy have improved, which has not yet been extensively studied. Thus...
Saved in:
| Main Authors: | Marta Anna Sobas, Amin T. Turki, Angela Villaverde Ramiro, Alberto Hernández Sánchez, Javier Martinez Elicegui, Teresa González, Raúl Azibeiro Melchor, María Abáigar, Laura Tur, Daniele Dall'Olio, Eric Sträng, Jesse M. Tettero, Gastone Castellani, Axel Benner, Konstanze Döhner, Christian Thiede, Klaus H. Metzeler, Torsten Haferlach, Frederik Damm, Rosa Ayala, Joaquín Martínez-López, Ken I Mills, Jorge Sierra, Sören Lehmann, Matteo G. Della Porta, Jiri Mayer, Dirk Reinhardt, Rubén Villoria Medina, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian J.P Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-11-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11814 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
by: Sibylle Cocciardi, et al.
Published: (2025-01-01) -
O desenvolvimento da fotografia como um instrumento científico no século XIX
by: Rafael Luis dos Santos Dall'olio
Published: (2025-03-01) -
The Role of the Sd<sup>a</sup> Carbohydrate Antigen and That of Its Cognate Glycosyltransferase B4GALNT2 in Health and Disease
by: Martina Duca, et al.
Published: (2025-03-01) -
A working school: the Mattatoio student residence project in Rome
by: Tommaso Berretta, et al.
Published: (2018-06-01) -
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
by: Frank G. Rücker, et al.
Published: (2024-12-01)